Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
5420.00Today’s High
5485.4052W low
3186.3052W High
5520.00Open Price
5485.00Prev. Close
3530.40Volume
13400.00Value
72872550.00Fundamentals
Market Cap Cr
65022.40
Price to Earnings
41.30
Price to Book Value
6.90
Dividend Yield
0.80
PE to Growth
0.80
Op Revenue TTM Cr
12634.36
Net Profit TTM Cr
1573.19
Cash From Operating Activity Cr
1682.50
Return on Equity %
10.88
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
18 May, 2024
57.7
Week
54.8
Month
56.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
5447.90
PIVOT
First Resistance
5475.80
Second Resistance
5513.35
Third Resistance
5541.25
First Support
5410.35
Second Support
5382.45
Third Support
5344.90
Relative Strength Index
71.08
Money Flow Index
71.21
MACD
129.63
MACD Signal
78.78
Average True Range
143.45
Average Directional Index
29.62
Rate of Change (21)
16.93
Rate of Change (125)
25.16
Commodity Channel Index
146
Williams %R
-6.3
BETA
1 Month
0.74
3 Month
0.63
1 Year
0.38
3 Year
0.08
PRICE CHANGE ANALYSIS
↑ 6.03%
1 Week
Low
High
5081
5485.45
↑ 16.93%
1 Month
Low
High
4567.05
5485.45
↓ -0.12%
3 Months
Low
High
4567.05
5520
↑ 22.25%
6 Months
Low
High
4380.8
5520
↑ 63.49%
1 Year
Low
High
3186.3
5520
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 2590.25 | 2696.43 | 2317.87 | 2314.59 | 2357.46 | 2535.13 | 2113.66 | 2060.54 | 2244.08 | 2407.20 | 2317.88 | |
| Operating Expenses Qtr | 1925.33 | 1979.99 | 1919.42 | 1906.00 | 1840.75 | 2055.81 | 1875.04 | 1806.62 | 1708.58 | 1776.15 | 1728.10 | |
| Operating Profit Qtr | 569.26 | 654.60 | 333.75 | 331.99 | 455.97 | 405.68 | 183.31 | 199.69 | 472.26 | 587.84 | 550.57 | |
| EBIDT Qtr Cr | 613.61 | 716.44 | 398.45 | 408.59 | 516.71 | 479.32 | 238.62 | 253.92 | 535.50 | 631.05 | 589.78 | |
| Depreciation Qtr | 58.12 | 59.02 | 58.11 | 57.16 | 58.14 | 57.74 | 56.81 | 55.01 | 58.43 | 53.82 | 51.72 | |
| Net Profit Qtr | 504.23 | 646.51 | 271.44 | 254.79 | 388.89 | 350.69 | 140.10 | 76.88 | 437.09 | 558.01 | 469.27 | |
| Basic EPS Qtr | 42.17 | 54.07 | 22.70 | 21.31 | 32.53 | 29.33 | 11.72 | 6.43 | 36.56 | 46.67 | 39.25 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 9320.84 | 9029.70 | 7409.69 | 6773.06 | 5781.67 | |
| Operating Expenses Annual Cr | 7677.60 | 7019.45 | 5270.75 | 5209.43 | 4668.38 | |
| Operating Profit Annual | 1376.95 | 1810.36 | 1948.93 | 1467.65 | 1045.71 | |
| Operating Profit Margin Annual % | 14.77 | 20.05 | 26.30 | 21.67 | 18.09 | |
| Total Expenses Annual Cr | 7993.85 | 7276.33 | 5512.61 | 5434.98 | 4837.71 | |
| EBIDT Annual Cr | 1643.24 | 2010.25 | 2138.94 | 1563.63 | 1113.29 | |
| EBIDT Annual margin % | 17.63 | 22.26 | 28.87 | 23.09 | 19.26 | |
| Depreciation | 229.85 | 218.98 | 198.93 | 186.84 | 141.07 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1134.47 | 1541.25 | 1685.08 | 1264.42 | 799.84 | |
| Net Profit Annual | 1134.47 | 1541.25 | 1685.08 | 1264.42 | 799.84 | |
| Basic EPS Annual | 94.88 | 128.90 | 140.93 | 105.75 | 66.90 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 9349.85 | 8743.66 | 7625.75 | 6280.44 | 5465.21 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 336.54 | 301.75 | 237.04 | 245.63 | 157.07 | |
| Total Current Liabilities Annual Cr | 3044.83 | 4123.76 | 2909.94 | 2579.76 | 1669.87 | |
| Total Capital Plus Liabilities Annual Cr | 12731.22 | 13169.17 | 10772.73 | 9105.83 | 7292.15 | |
| Fixed Assets Annual | 2053.84 | 2114.52 | 2081.62 | 2150.42 | 1987.97 | |
| Total Non Current Assets Annual | 5959.01 | 6308.56 | 5141.19 | 4876.65 | 4211.47 | |
| Total Current Assets Annual | 6772.21 | 6860.61 | 5631.54 | 4229.18 | 3080.68 | |
| Total Assets Annual | 12731.22 | 13169.17 | 10772.73 | 9105.83 | 7292.15 | |
| Contingent Liabilities plus Commitments Annual Cr | 314.71 | 359.22 | 376.65 | 329.70 | 406.92 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1437.42 | 1299.34 | 1324.48 | 681.78 | 745.09 | |
| Cash from Investing Activity Annual | 197.04 | -1669.33 | -1120.99 | -995.17 | -313.06 | |
| Cash from Financing Annual Activity | -1711.27 | 436.59 | -208.96 | 172.64 | -275.75 | |
| Net Cash Flow Annual | -76.81 | 66.60 | -5.47 | -140.75 | 156.28 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 782.09 | 731.38 | 637.87 | 525.34 | 457.15 | |
| ROE Annual % | 12.13 | 17.62 | 22.09 | 20.13 | 14.63 | |
| ROCE Annual % | 14.59 | 19.80 | 24.67 | 21.09 | 17.29 | |
| Total Debt to Total Equity Annual | 0.12 | 0.26 | 0.18 | 0.19 | 0.09 | |
| EBDIT Annual Margin % | 18.14 | 22.76 | 29.62 | 23.41 | 19.48 |
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 3417.51 | 3503.36 | 3033.56 | 2971.27 | 3086.24 | 3130.04 | 2627.79 | 2504.38 | 2672.50 | 2841.95 | 2778.01 | |
| Operating Expenses Qtr | 2616.28 | 2693.44 | 2578.53 | 2549.35 | 2441.86 | 2625.46 | 2373.14 | 2146.63 | 2120.53 | 2175.61 | 2138.50 | |
| Operating Profit Qtr | 707.59 | 746.73 | 389.19 | 353.25 | 599.05 | 453.91 | 203.24 | 337.23 | 498.45 | 624.38 | 592.86 | |
| EBIDT Qtr Cr | 749.92 | 752.26 | 455.03 | 318.94 | 644.38 | 504.58 | 254.65 | 342.79 | 551.97 | 666.34 | 639.51 | |
| Depreciation Qtr | 69.56 | 73.90 | 72.41 | 78.32 | 78.44 | 77.40 | 76.26 | 83.14 | 77.46 | 72.83 | 70.53 | |
| Net Profit Qtr | 594.96 | 620.52 | 286.73 | 70.98 | 454.71 | 330.84 | 127.64 | 107.58 | 525.66 | 544.26 | 468.12 | |
| Basic EPS Qtr | 49.76 | 51.90 | 23.98 | 5.94 | 38.03 | 27.67 | 10.68 | 9.00 | 43.96 | 45.52 | 39.15 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 11815.34 | 10796.84 | 9098.22 | 8448.58 | 7444.89 | |
| Operating Expenses Annual Cr | 9989.81 | 8581.27 | 6922.62 | 6870.97 | 6242.42 | |
| Operating Profit Annual | 1609.45 | 2052.92 | 1942.39 | 1473.39 | 1114.77 | |
| Operating Profit Margin Annual % | 13.62 | 19.01 | 21.35 | 17.44 | 14.97 | |
| Total Expenses Annual Cr | 10407.59 | 8937.60 | 7256.12 | 7188.79 | 6490.23 | |
| EBIDT Annual Cr | 1825.53 | 2215.57 | 2175.60 | 1577.61 | 1202.47 | |
| EBIDT Annual margin % | 15.45 | 20.52 | 23.91 | 18.67 | 16.15 | |
| Depreciation | 310.42 | 303.96 | 274.58 | 252.76 | 193.18 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1006.81 | 1680.32 | 1617.77 | 1149.31 | 773.64 | |
| Net Profit Annual | 984.17 | 1645.62 | 1585.02 | 1127.07 | 760.51 | |
| Basic EPS Annual | 82.31 | 137.63 | 132.57 | 94.26 | 63.61 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 9045.29 | 8637.90 | 7376.73 | 6160.67 | 5439.34 | |
| Minority Interest Liability Annual Cr | 389.71 | 209.43 | 181.28 | 148.30 | 132.61 | |
| Total Non Current Liabilities Annual Cr | 614.50 | 416.52 | 357.20 | 391.99 | 418.71 | |
| Total Current Liabilities Annual Cr | 3707.15 | 4805.34 | 3604.05 | 3244.58 | 2217.53 | |
| Total Capital Plus Liabilities Annual Cr | 13756.65 | 14069.19 | 11519.26 | 9945.54 | 8208.19 | |
| Fixed Assets Annual | 2592.90 | 2838.12 | 2790.87 | 2872.53 | 2642.84 | |
| Total Non Current Assets Annual | 5026.95 | 5633.76 | 4590.44 | 4439.89 | 3992.06 | |
| Total Current Assets Annual | 8729.70 | 8435.43 | 6928.82 | 5505.65 | 4216.13 | |
| Total Assets Annual | 13756.65 | 14069.19 | 11519.26 | 9945.54 | 8208.19 | |
| Contingent Liabilities plus Commitments Annual Cr | 410.26 | 425.90 | 449.06 | 357.59 | 436.60 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 1682.50 | 1111.02 | 1264.90 | 585.08 | 779.65 | |
| Cash from Investing Activity Annual | 112.84 | -1435.13 | -998.54 | -741.35 | -316.39 | |
| Cash from Financing Annual Activity | -1760.82 | 379.57 | -271.75 | 79.15 | -378.94 | |
| Net Cash Flow Annual | 34.52 | 55.46 | -5.39 | -77.12 | 84.32 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 789.21 | 740.05 | 632.20 | 527.73 | 466.08 | |
| ROE Annual % | 10.88 | 19.05 | 21.48 | 18.29 | 13.98 | |
| ROCE Annual % | 15.07 | 20.63 | 24.01 | 19.77 | 16.84 | |
| Total Debt to Total Equity Annual | 0.14 | 0.30 | 0.23 | 0.26 | 0.17 | |
| EBDIT Annual Margin % | 15.73 | 20.83 | 24.54 | 18.90 | 16.34 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Icici Prudential Elss Tax Saver Fund | 2.24 | 75045398 | - | - |
| Hdfc Life Insurance Company Limited | 1.4 | 75045401 | - | - |
| Government Pension Fund Global | 1.06 | 75045407 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Sarandhar Singh* (please refer notes) | 20.66 | 75045368 | 0 | 0 |
| Basudeo Narain Singh | 7.27 | 75045369 | 0 | 0 |
| Mritunjay Kumar Singh | 6.42 | 75045370 | 0 | 0 |
| Madhurima Singh$ (please refer notes) | 5.39 | 75045371 | 0 | 0 |
| Madhurima Singh@ (please refer notes) | 2.59 | 75045372 | 0 | 0 |
| Jayanti Sinha | 2.46 | 75045373 | 0 | 0 |
| Seema Singh | 2.46 | 75045374 | 0 | 0 |
| Archana Singh | 2 | 75045375 | 0 | 0 |
| Aniruddha Singh& (please refer notes) | 1.01 | 75045376 | 0 | 0 |
| Divya Singh& (please refer notes) | 1.01 | 75045377 | 0 | 0 |
| Meghna Singh | 1.01 | 75045378 | 0 | 0 |
| Shrey Shree Anant Singh | 1 | 75045379 | 0 | 0 |
| Madhurima Singh& (please refer notes) | 0.79 | 75045380 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Dsp Midcap Fund | 2.53 | 75045397 |
| Icici Prudential Elss Tax Saver Fund | 2.24 | 75045398 |
| Nippon Life India Trustee Ltd-A/C Nippon India Growth Fund | 1.56 | 75045399 |
| Government Pension Fund Global | 1.06 | 75045407 |
| Hdfc Life Insurance Company Limited | 1.4 | 75045401 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Kishor Kumar Singh | 2.86 | 75045417 |
| Alok Kumar | 2.31 | 75045418 |
| Ashok Kumar | 2.26 | 75045419 |
| Rajesh Kumar | 2.25 | 75045420 |
| Deepak Kumar Singh | 2.16 | 75045421 |
| Rajeev Ranjan | 2.08 | 75045422 |
| Nawal Kishore Singh | 1.01 | 75045423 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 16, 2024 | 35 | INTERIM | Feb 17, 2024 | Equity Share |
| Aug 10, 2023 | 10 | FINAL | Aug 10, 2023 | Equity Share |
| Feb 17, 2023 | 25 | SPECIAL | Feb 18, 2023 | Equity Share |
| Feb 17, 2023 | 15 | INTERIM | Feb 18, 2023 | Equity Share |
| Aug 08, 2022 | 4 | FINAL | Aug 10, 2022 | Equity Share |
| Feb 10, 2022 | 30 | INTERIM | Feb 12, 2022 | Equity Share |
| Aug 09, 2021 | 5 | FINAL | Aug 10, 2021 | Equity Share |
| Feb 11, 2021 | 25 | INTERIM | Feb 13, 2021 | Equity Share |
| Aug 10, 2020 | 3 | FINAL | Aug 11, 2020 | Equity Share |
| Feb 13, 2020 | 22 | INTERIM | Feb 15, 2020 | Equity Share |
| Aug 19, 2019 | 8 | FINAL | Aug 20, 2019 | Equity Share |
| Feb 15, 2019 | 8 | INTERIM | Feb 18, 2019 | Equity Share |
| Aug 23, 2018 | 7 | FINAL | Aug 24, 2018 | Equity Share |
| Feb 16, 2018 | 6 | INTERIM | Feb 20, 2018 | Equity Share |
| Aug 31, 2017 | 9 | FINAL | Sep 01, 2017 | Equity Share |
| Nov 23, 2016 | 6 | INTERIM | Nov 24, 2016 | Equity Share |
| Mar 18, 2016 | 9.7 | INTERIM | Mar 21, 2016 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Feb 09, 2024 | Quarterly Results & Interim Dividend | - |
| Nov 07, 2023 | Quarterly Results | - |
| Aug 10, 2023 | Quarterly Results | - |
| May 19, 2023 | Audited Results & Final Dividend | - |
| Feb 10, 2023 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2022 | Quarterly Results | - |
| Aug 05, 2022 | Quarterly Results | - |
| May 13, 2022 | Audited Results & Final Dividend | - |
| Feb 04, 2022 | Quarterly Results & Interim Dividend | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 06, 2021 | Quarterly Results | - |
| May 25, 2021 | Audited Results & Final Dividend | - |
| Feb 05, 2021 | Quarterly Results & Interim Dividend | - |
| Nov 06, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| Jun 05, 2020 | Audited Results & Final Dividend | - |
| Feb 07, 2020 | Quarterly Results & Interim Dividend | - |
| Nov 11, 2019 | Quarterly Results | - |
| Aug 12, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Final Dividend | - |
| Feb 08, 2019 | Quarterly Results & Interim Dividend | - |
| Nov 02, 2018 | Quarterly Results | - |
| Aug 10, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results & Final Dividend | - |
| Feb 09, 2018 | Quarterly Results & Interim Dividend | - |
| Nov 10, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 26, 2017 | Audited Results & Final Dividend | - |
| Feb 10, 2017 | Quarterly Results | - |
| Nov 11, 2016 | Quarterly Results & Interim Dividend | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 27, 2016 | Audited Results | - |
| Mar 09, 2016 | 2nd Interim Dividend | Approved the Option Agreement with Mr. Tushar Kumar for grant of Option to purchase the trust units held by the Company in Avenue Venture Real Estate Fund. |
| Feb 12, 2016 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
16 May 2024
Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 29Th May, 2024.
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Alkem Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024, inter alia, to consider and approve (i) the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2024; and (ii) to consider and recommend Final Dividend, if any, for financial year ended 31st March, 2024. Kindly take note of the same.
15 May 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
07 May 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
30 Apr 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
26 Apr 2024
Alkem Laboratories Ltd - 539523 - Application For Reclassification Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 31A of SEBI (LODR) Regulations, 2015 and pursuant to the receipt of approval from the shareholders of the Company through Postal Ballot on 05th April, 2024, the Company has submitted the application to BSE Limited and The National Stock Exchange of India Limited for the Reclassification of certain members of the Promoter Group of the Company.
25 Apr 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
23 Apr 2024
Alkem Laboratories Ltd - 539523 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAlkem Laboratories Ltd 2CIN NO.L00305MH1973PLC174201 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Manish Narang Designation: President Legal Company Secretary and Compliance Officer EmailId: manishnarang@alkem.com Name of the Chief Financial Officer: Nitin Agrawal Designation: President Finance and Chief Financial Officer EmailId: nitin.agrawal@alkem.com Date: 23/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
16 Apr 2024
Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.
12 Apr 2024
Alkem Laboratories Ltd - 539523 - Reply To BSE Email - Additional Details Required Under SEBI Circular Dated July 13, 2023, For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Please find attached herewith our response with respect to your email dated 12th April, 2024.
11 Apr 2024
Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024.
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the year ended 31st March, 2024. Kindly take the same on record.
